UMB Bank’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30K Sell
400
-238
-37% -$15.3K ﹤0.01% 1522
2026
Q1
$36K Buy
638
+56
+10% +$3.65K ﹤0.01% 1381
2025
Q4
$46.6K Buy
582
+306
+111% +$20.6K ﹤0.01% 1269
2025
Q3
$13.5K Sell
276
-393
-59% -$24.3K ﹤0.01% 1566
2025
Q2
$49.9K Buy
669
+320
+92% +$21.2K ﹤0.01% 1118
2025
Q1
$22.2K Buy
349
+48
+16% +$3.27K ﹤0.01% 1295
2024
Q4
$23.5K Buy
301
+174
+137% +$14K ﹤0.01% 1185
2024
Q3
$10.2K Buy
127
+100
+370% +$8.08K ﹤0.01% 1480
2024
Q2
$2.23K Sell
27
-11
-29% -$968 ﹤0.01% 1734
2024
Q1
$3.24K Sell
38
-27
-42% -$2.12K ﹤0.01% 1431
2023
Q4
$5.56K Sell
65
-13
-17% -$1.12K ﹤0.01% 1394
2023
Q3
$6.99K Buy
78
+65
+500% +$5.8K ﹤0.01% 1358
2023
Q2
$1.11K Hold
13
﹤0.01% 1580
2023
Q1
$1.08K Hold
13
﹤0.01% 1588
2022
Q4
$1K Hold
13
﹤0.01% 1622
2022
Q3
$1K Sell
13
-10
-43% -$718 ﹤0.01% 1664
2022
Q2
$1K Hold
23
﹤0.01% 1830
2022
Q1
$1K Hold
23
﹤0.01% 1905
2021
Q4
$1K Buy
+23
New +$1.4K ﹤0.01% 1913

Other funds holding HAE

UMB Bank's HAE Position: Q2 2026 in Review

UMB Bank reduced its Haemonetics (HAE) stake by 37% in Q2 2026, selling an estimated $15.3K and leaving 400 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #1522.

UMB Bank first reported a position in HAE in Q4 2021 and has held it in 19 quarters since. The position peaked at $49.9K in Q2 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • UMB Bank held 400 shares of Haemonetics worth $30K as of Q2 2026.
  • UMB Bank sold 238 Haemonetics shares in Q2 2026, an estimated $15.3K.
  • Haemonetics made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1522 holding.
  • UMB Bank first reported a position in Haemonetics in Q4 2021 and has held it in 19 quarters since.
  • UMB Bank's Haemonetics position peaked at $49.9K in Q2 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.